- Report
- May 2026
- 186 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 276 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 486 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 297 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 371 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 192 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 186 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 169 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 268 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 304 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 154 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 212 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 229 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 174 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 208 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 225 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 204 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- January 2026
- 185 Pages
Global
From €3969EUR$4,500USD£3,441GBP
- Report
- February 2026
- 250 Pages
Global
From €3960EUR$4,490USD£3,434GBP
- Report
- November 2025
- 200 Pages
Global
From €7012EUR$7,950USD£6,080GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more